Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV.
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
HIV Research for Prevention 2018: From Research to Impact Conference Summary and Highlights.
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection.
Glutaminolysis and lipoproteins are key factors in late immune recovery in successfully treated HIV-infected patients.
HIV-1 envelope glycoproteins isolated from Viremic Non-Progressor individuals are fully functional and cytopathic.
Production of HIV-1-based virus-like particles for vaccination: achievements and limits.
CD4 recovery is associated with genetic variation in IFNγ and IL19 genes.
NNRTI-induced HIV-1 protease-mediated cytotoxicity induces rapid death of CD4 T cells during productive infection and latency reversal.
Combined assessment of peritumoral Th1/Th2 polarization and peripheral immunity as a new biomarker in the prediction of BCG response in patients with high-risk NMIBC.